Skip to main content

Critical Care Reviews Podcast ↓

WHO REACT Group

Interleukin 6 Antagonists in COVID-19 Prospective Meta Analysis

With Prof Manu Shankar-Hari

Prof Manu Shankar-Hari

Professor in Critical Care Medicine at King's College London and an NIHR Clinician Scientist

Published Trial

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19A Meta-analysis. JAMA 2021;epublished July 6th